| Anti-CD73 antibodies and uses thereof |
2022-4-29 |
2022-5-19 |
|
| Single domain pd-l1 antibodies |
2022-4-26 |
2022-11-03 |
|
| Anti-pd-l1 antibody and il-7 fusions |
2022-4-20 |
2022-7-06 |
|
| Novel cd47 monoclonal antibody and use of the same |
2022-3-09 |
2022-5-24 |
|
| Anti-claudin 18.2 and anti-4-1bb bispecific antibodies and uses thereof |
2022-3-01 |
2022-11-03 |
|
| Formulation containing soluble gp130 dimer and method for using same |
2021-12-31 |
2022-7-07 |
|
| Anti-pd-l1 antibodies and uses thereof |
2021-12-28 |
2022-4-21 |
|
| Fusion proteins containing cd47 antibodies and cytokines |
2021-12-15 |
2022-1-20 |
|
| Anti-CXCL13 antibodies for treating autoimmune diseases and cancer |
2021-11-05 |
2021-12-16 |
|
| Methods for mitigating interference by therapeutic anti-cd47 antibodies in pre- … |
2021-10-14 |
2022-8-01 |
|
| Novel anti-cd47 antibodies and uses thereof |
2021-10-14 |
2022-8-01 |
|
| Pharmaceutical composition comprising cd47 antibody and pd-1/pd-l1 inhibitor |
2021-9-22 |
2022-3-24 |
|
| Combination therapies targeting c5ar and pd-1/pd-l1 pathways |
2021-9-17 |
2022-3-24 |
|
| Anti-ifnar1 antibodies for treating autoimmune diseases |
2021-7-12 |
2021-11-11 |
|
| Anti-pd-l1/anti-4-1bb bispecific antibodies and uses thereof |
2021-5-28 |
2021-7-29 |
|
| Formulations of anti-cd73 antibodies |
2021-5-08 |
2022-7-07 |
|
| Pharmaceutical compositions containing anti-cd47 antibodies |
2021-4-29 |
2023-3-08 |
|
| Human pd-l1 antibodies |
2021-3-10 |
2021-4-29 |
|
| Methods for detecting and quantifying biological modifications in antibodies |
2021-3-09 |
2021-9-16 |
|
| Novel cd47 antibodies and methods of using same |
2021-1-17 |
2021-3-01 |
|
| Anti-gm-csf antibodies and uses thereof |
2020-12-02 |
2021-3-18 |
|
| MULTISPECIFIC ANTI-PD-L1/ANTI-B7-H3 ANTIBODIES AND USES THEREOF |
2020-11-23 |
2022-10-18 |
|
| Constant-temperature incubator for bacterial culture |
2020-11-20 |
2021-7-30 |
2021-7-30 |
| Test tube rack assembly for test |
2020-11-20 |
2021-8-06 |
2021-8-06 |
| Multifunctional cell culture plate for biological experiments |
2020-11-20 |
2021-8-10 |
2021-8-10 |
| Multifunctional tweezers for experiments |
2020-11-20 |
2021-7-16 |
2021-7-16 |
| Liquid-transfering gun head for it is biological experiments |
2020-11-20 |
2021-8-10 |
2021-8-10 |
| Biological assay is with drying frame |
2020-11-20 |
2021-6-25 |
2021-6-25 |
| Biochemical incubator for biological assay |
2020-11-20 |
2021-8-03 |
2021-8-03 |
| Biological assay fume hood |
2020-11-20 |
2021-7-16 |
2021-7-16 |
| Anti-PD-L1 antibodies and uses thereof |
2020-8-11 |
2020-9-03 |
|
| Bifunctional molecules with il-7 activity |
2020-7-27 |
2021-1-28 |
|
| Antibodies to t cell immunoreceptor with ig and itim domains (tigit) and uses … |
2020-7-23 |
2020-9-30 |
|
| Modified ck and ch1 domains |
2020-7-09 |
2020-8-31 |
|
| Anti-lag-3 antibodies and uses thereof |
2019-11-18 |
2020-3-05 |
|
| System and method for determining vehicle navigation in response to broken or … |
2019-9-04 |
2021-3-04 |
|
| anti-PD-L1/anti-LAG 3 bispecific antibodies and uses thereof |
2019-8-21 |
2021-8-13 |
|
| anti-PD-L1/anti-LAG 3 bispecific antibodies and uses thereof |
2019-8-21 |
2020-1-10 |
|
| anti-CD 73 anti-PD-L1 bispecific antibodies |
2019-7-25 |
2020-12-04 |
|
| Fusion proteins containing cd47 antibodies and cytokines |
2019-4-30 |
2020-5-22 |
|
| Anti-pd-l1 antibodies and uses thereof |
2017-6-13 |
2021-4-30 |
|
| Anti-lymphocyte activation gene-3 (lag-3) antibodies and uses thereof |
2017-2-22 |
2018-8-30 |
|
| GM CSF antibody and application thereof |
2016-9-19 |
2018-3-27 |
|
| GM CSF antibody and application thereof |
2016-9-19 |
2018-3-27 |
|
| Fused polypeptide and application thereof containing glucagon-like-peptide-1 … |
2014-12-31 |
2019-9-06 |
|